The UK's National Institute for Health and Care Excellence (NICE) has declined to recommend two new Alzheimer's drugs for routine NHS use in England. While disappointing for some families affected ...

See the latest NICE Ltd ADR stock price (NICE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Evidence-based recommendations on sparsentan (Filspari) for treating primary immunoglobulin A (IgA) nephropathy in adults. Last reviewed: 25 June 2025 Next review: This guidance will be reviewed if ...

NICE technology appraisals for cancer drugs are often delayed - but who's really to blame? This post investigates how the DHSC contributes to hold-ups in access to innovative cancer treatments.

President Donald Trump publicly insulted two reporters while taking questions at the NATO summit, which was held at the Hague.“Does anyone have any questions?” Trump asked.A wide shot of the ...

(Bloomberg) — It had all been going so well. Since Mark Carney replaced Justin Trudeau as prime minister, Canada’s relationship with the White House appeared to be functional again, on the mend after ...

The NICE HealthTech programme combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme. To avoid duplication, this ...

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

Nice Weather Forecasts. Weather Underground provides local & long-range weather forecasts, weatherreports, maps & tropical weather conditions for the Nice area.